The developed diagnostic algorithm, which includes PTN, FGF-21, AST, and sex, demonstrates strong performance independent of gender, making it a valuable tool for identifying MASH in morbidly obese subjects. Here, PTN is linked to metabolic dysfunction-associated steatohepatitis.